|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 112, Issue 15 2597-2606, Copyright © 1999 by Company of Biologists
JOURNAL ARTICLES |
R Giuliani, M Bastaki, D Coltrini and M Presta
Unit of General Pathology and Immunology, Department of Biomedical Sciences and Biotechnology, University of Brescia, Italy.
Downstream signaling triggered by the binding of fibroblast growth factor-2 (FGF2) to its tyrosine-kinase receptors involves the activation of mitogen-activated protein kinase kinase (MEK) with consequent phosphorylation of extracellular signal-regulated kinases (ERKs). Here we demonstrate that FGF2 induces ERK1/2 activation in bovine aortic endothelial (BAE) cells and that the continuous presence of the growth factor is required for sustained ERK1/2 phosphorylation. This is prevented by the MEK inhibitors PD 098059 and U0126, which also inhibit FGF2-mediated upregulation of urokinase-type plasminogen activator (uPA) and in vitro formation of capillary-like structures in three-dimensional type I collagen gel. Various FGF2 mutants originated by deletion or substitution of basic amino acid residues in the amino terminus or in the carboxyl terminus of FGF2 retained the capacity to induce a long-lasting activation of ERK1/2 in BAE cells. Among them, K128Q/R129Q-FGF2 was also able to stimulate uPA production and morphogenesis whereas R129Q/K134Q-FGF2 caused uPA upregulation only. In contrast, K27, 30Q/R31Q-FGF2, K128Q/K138Q-FGF2 and R118,129Q/K119,128Q-FGF2 exerted a significant uPA-inducing and morphogenic activity in an ERK1/2-dependent manner only in the presence of heparin. Furthermore, no uPA upregulation and morphogenesis was observed in BAE cells treated with the deletion mutant (delta)27-32-FGF2 even in the presence of soluble heparin. Thus, mutational analysis of FGF2 dissociates the capacity of the growth factor to induce a persistent activation of ERK1/2 from its ability to stimulate uPA upregulation and/or in vitro angiogenesis. In conclusion, the data indicate that ERK1/2 phosphorylation is a key step in the signal transduction pathway switched on by FGF2 in endothelial cells. Nevertheless, a sustained ERK1/2 activation is not sufficient to trigger uPA upregulation and morphogenesis. FGF2 mutants may represent useful tools to dissect the signal transduction pathway(s) mediating the complex response elicited by an angiogenic stimulus in endothelial cells.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Kunimasa, M.-R. Ahn, T. Kobayashi, R. Eguchi, S. Kumazawa, Y. Fujimori, T. Nakano, T. Nakayama, K. Kaji, and T. Ohta Brazilian Propolis Suppresses Angiogenesis by Inducing Apoptosis in Tube-forming Endothelial Cells through Inactivation of Survival Signal ERK1/2 Evid. Based Complement. Altern. Med., April 7, 2009; (2009) nep024v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-J. Park, H.-J. Kwak, H.-C. Lee, D.-H. Yoo, I.-C. Park, M.-S. Kim, S.-H. Lee, C. H. Rhee, and S.-I. Hong Nerve Growth Factor Induces Endothelial Cell Invasion and Cord Formation by Promoting Matrix Metalloproteinase-2 Expression through the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway and AP-2 Transcription Factor J. Biol. Chem., October 19, 2007; 282(42): 30485 - 30496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. V. Wesley, M. McGroarty, and A. Homoyouni Dipeptidyl Peptidase Inhibits Malignant Phenotype of Prostate Cancer Cells by Blocking Basic Fibroblast Growth Factor Signaling Pathway Cancer Res., February 15, 2005; 65(4): 1325 - 1334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Kessler, N. Shraga-Heled, T. Lange, N. Gutmann-Raviv, E. Sabo, L. Baruch, M. Machluf, and G. Neufeld Semaphorin-3F Is an Inhibitor of Tumor Angiogenesis Cancer Res., February 1, 2004; 64(3): 1008 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Taverna, G. Ghersi, A. Ginestra, S. Rigogliuso, S. Pecorella, G. Alaimo, F. Saladino, V. Dolo, P. Dell'Era, A. Pavan, et al. Shedding of Membrane Vesicles Mediates Fibroblast Growth Factor-2 Release from Cells J. Biol. Chem., December 19, 2003; 278(51): 51911 - 51919. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ishisaki, H. Hayashi, A.-J. Li, and T. Imamura Human Umbilical Vein Endothelium-derived Cells Retain Potential to Differentiate into Smooth Muscle-like Cells J. Biol. Chem., January 3, 2003; 278(2): 1303 - 1309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kanda, Y. Mochizuki, Y. Miyata, H. Kanetake, and N. Yamamoto Effects of Vitamin D3-Binding Protein-Derived Macrophage Activating Factor (GcMAF) on Angiogenesis J Natl Cancer Inst, September 4, 2002; 94(17): 1311 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rusnati, C. Urbinati, E. Tanghetti, P. Dell'Era, H. Lortat-Jacob, and M. Presta Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2 PNAS, April 2, 2002; 99(7): 4367 - 4372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Stefansson, E. Petitclerc, M. K. K. Wong, G. A. McMahon, P. C. Brooks, and D. A. Lawrence Inhibition of Angiogenesis in Vivo by Plasminogen Activator Inhibitor-1 J. Biol. Chem., March 9, 2001; 276(11): 8135 - 8141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rusnati, C. Urbinati, E. Tanghetti, P. Dell'Era, H. Lortat-Jacob, and M. Presta Cell membrane GM1 ganglioside is a functional coreceptor for fibroblast growth factor 2 PNAS, April 2, 2002; 99(7): 4367 - 4372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Cao, E. Brakenhielm, C. Wahlestedt, J. Thyberg, and Y. Cao Leptin induces vascular permeability and synergistically stimulates angiogenesis with FGF-2 and VEGF PNAS, May 22, 2001; 98(11): 6390 - 6395. [Abstract] [Full Text] [PDF]
|
|
